<DOC>
	<DOCNO>NCT01125306</DOCNO>
	<brief_summary>Xal-Ease novel Pfizer-Pharmacia device aim significantly facilitate Xalatan/Xalacom instillation avoid loss Xalatan/Xalacom eye drop due incorrect instillation . Patients Xalatan/Xalacom consumed one bottle per month within year accord consumption data draw Clalit Health Services database , use Xal-Ease device year . The device expect reduce consumption bottle result save money patient medical care provider .</brief_summary>
	<brief_title>Efficiency XAL-EASE Device Glaucoma and/or Ocular Hypertension ( OHT ) Patients , Treated With Xalatan Xalacom</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Patients glaucoma hypertension treat Xalatan/Xalacom consume one bottle per month within year prior initiation study . Patients young 18 year , Patients severe manual disability , Patients impaired cognition mentality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Drug consumption</keyword>
	<keyword>The Xal-Ease device</keyword>
	<keyword>Patient 's compliance</keyword>
	<keyword>Using novel Pfizer-Pharmacia device facilitate Xalatan/Xalacom instillation avoid loss eye drop</keyword>
</DOC>